[go: up one dir, main page]

ATE391790T1 - Rekombinante expression von heterologen nukleinsäuren in protozoen - Google Patents

Rekombinante expression von heterologen nukleinsäuren in protozoen

Info

Publication number
ATE391790T1
ATE391790T1 AT00905982T AT00905982T ATE391790T1 AT E391790 T1 ATE391790 T1 AT E391790T1 AT 00905982 T AT00905982 T AT 00905982T AT 00905982 T AT00905982 T AT 00905982T AT E391790 T1 ATE391790 T1 AT E391790T1
Authority
AT
Austria
Prior art keywords
nucleic acids
protozoa
multifiliis
transformants
beta
Prior art date
Application number
AT00905982T
Other languages
English (en)
Inventor
Jacek Gaertig
Harry Dickerson
Theodore Clark
Original Assignee
Univ Georgia Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Georgia Res Found filed Critical Univ Georgia Res Found
Application granted granted Critical
Publication of ATE391790T1 publication Critical patent/ATE391790T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/002Protozoa antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00905982T 1999-02-04 2000-02-04 Rekombinante expression von heterologen nukleinsäuren in protozoen ATE391790T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11863499P 1999-02-04 1999-02-04
US12237299P 1999-03-02 1999-03-02
US12490599P 1999-03-17 1999-03-17
US13112199P 1999-04-27 1999-04-27

Publications (1)

Publication Number Publication Date
ATE391790T1 true ATE391790T1 (de) 2008-04-15

Family

ID=27494214

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00905982T ATE391790T1 (de) 1999-02-04 2000-02-04 Rekombinante expression von heterologen nukleinsäuren in protozoen

Country Status (5)

Country Link
EP (2) EP1151104A1 (de)
AT (1) ATE391790T1 (de)
AU (2) AU2756300A (de)
DE (1) DE60038542D1 (de)
WO (2) WO2000046373A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7326568B2 (en) 1999-02-04 2008-02-05 University Of Georgia Research Foundation, Inc. Recombinant expression of heterologous nucleic acids in protozoa
EP1485489A2 (de) * 2002-03-19 2004-12-15 Cilian AG Dna-sequenzen von sekretierten proteinen des ciliaten tetrahymena und deren verwendung
DE10214406A1 (de) * 2002-03-30 2003-10-09 Nutrinova Gmbh Verfahren und Marker zur einfachen Transformation und Selektion von rekombinanten Protisten
DE10214413A1 (de) * 2002-03-30 2003-10-09 Nutrinova Gmbh Expression von rekombinanten humanen Proteinen in Tetrahymena
US8361780B2 (en) 2005-06-30 2013-01-29 University Of Georgia Research Foundation, Inc. Biological system and assay for identifying modulators of tubulin ligases
JP5355561B2 (ja) * 2007-07-12 2013-11-27 コンピュゲン エルティーディー. 生物活性ペプチドおよびその使用方法
GB2471093A (en) * 2009-06-17 2010-12-22 Cilian Ag Viral protein expression in ciliates
GB201003701D0 (en) * 2010-03-05 2010-04-21 Cilian Ag System for the expression of a protein
GB201501081D0 (en) 2015-01-22 2015-03-11 Cilian Ag Use of enzymes with a wide pH activity range as medicaments for promoting digestion
WO2021260148A1 (en) 2020-06-24 2021-12-30 Cilian Ag New lipase enzyme
CA3212187A1 (en) 2021-04-09 2022-10-13 Marcus Wolf William HARTMANN Purification of proteins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780448A (en) * 1995-11-07 1998-07-14 Ottawa Civic Hospital Loeb Research DNA-based vaccination of fish
US7026156B1 (en) * 1999-02-04 2006-04-11 The University Of Georgia Research Foundation, Inc. Diagnostic and protective antigen gene sequences of ichthyophthirius

Also Published As

Publication number Publication date
EP1151118A1 (de) 2001-11-07
WO2000046381A1 (en) 2000-08-10
EP1151118B1 (de) 2008-04-09
AU2756300A (en) 2000-08-25
WO2000046373A1 (en) 2000-08-10
AU2756100A (en) 2000-08-25
DE60038542D1 (de) 2008-05-21
EP1151104A1 (de) 2001-11-07

Similar Documents

Publication Publication Date Title
ATE391790T1 (de) Rekombinante expression von heterologen nukleinsäuren in protozoen
WO2020198509A3 (en) Modified oligonucleotides with increased stability
DK1471926T3 (da) Sammensætninger og fremgangsmåder til terapeutisk anvendelse af en atonal-associeret sekvens
DE69434663D1 (de) Nukleotid-sequenzen zur kontrolle der exprimierung von dns-sequenzen in einem zellulärem wirt
CY1108638T1 (el) Πρωτεϊνη συντηξης των hiv ρυθμιστικων/επικουρικων πρωτεϊνων
DE60335637D1 (de) Vektoren auf transposonbasis und verfahren zur integration von nukleinsäuren
WO1999020766A3 (en) NOVEL MODIFIED NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS
WO2006071107A8 (en) Mite composition, use thereof, method for rearing a phytoseiid predatory mite, rearing system for rearing said phytoseiid predatory mite and methods for biological pest control on a crop
DE60227498D1 (de) Abgabe von mitteln zur krankheitskontrolle in aquakultur unter verwendung von bioaktive proteine enthaltender hefe
AR029644A1 (es) Proteina aislada, polinucleotido aislado, celula huesped transgenica, metodo para controlar una plaga que no es de mamiferos, cultivo biologicamente puro
DK1472344T3 (da) Bakteriofaglysin
WO2004010925A3 (en) Mammalian genes involved in viral infection and tumor suppression
DK1097233T3 (da) Promotor for vækstdifferentieringsfaktor og anvendelser deraf
DE60308695D1 (de) HERSTELLUNG VON STEREOISOMEREN VON (3ALPHA, 3ALPHA/BETA, 6ALPHA/BETA)HEXAHYDROFUROi2,3-böFURAN-3-OL
DK1242602T3 (da) Proteinekspressionssystemer for ikke-patogene kinetoplastidae
DE60328814D1 (de) Hm1.24 verwertende krebsvakzine
DK1023453T3 (da) TGC-fremgangsmåde til induktion af en målrettet, somatisk transgenitet
ATE290788T1 (de) Verbessertes verfahren zur bekämpfung von parasitosen in bienenstöcken
MX2024003412A (es) Terapia de regulon de arnm para el tratamiento de los trastornos por haploinsuficiencia.
WO2003047532A3 (en) Compositions and methods for the therapeutic use of an atonal-associated sequence for a gastrointestinal condition
DE60032293D1 (de) Lebende attenuierte bakterien zur verwendung als impfstoff
ATE364625T1 (de) Proteine aus yaba monkey tumor virus mit modulatorischer aktivität
HUP0400915A2 (hu) Növényi reprodukciós proteinek
EP1213351A3 (de) Nukleinsäure-Enzym, das durch Erkennung eines anderen Moleküls, die Aktivität zur Spaltung einer Ziel-RNA gewinnt
DK1633873T3 (da) Bakterier med forøgede niveauer af proteinsekretion, nukleotidsekvenser kodende for et SecA-protein med forøgede niveauer af proteinsekretion og fremgangsmåde til fremstilling af proteiner

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties